Sector valuations Replimune Group, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 15/06/2026 BST			5-day change	1st Jan Change
8.960 ^USD	+0.90%		-0.11%	-7.82%

06-01	Replimune Says Evaluating RP2 for Metastatic Uveal Melanoma in Phase 2/3 Trial; Shares Up Pre-Bell	MT
05-31	Replimune Group Presents Final First-In-Human Data for RP2 in Advanced Solid Tumors	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
REPLIMUNE GROUP, INC.	-2.64x	6.05x	-0.28x	68.38x	-2.41x	-1.62x	-	733M
LONZA GROUP AG	29.6x	3.79x	1.31x	5.25x	16.28x	22.85x	1.11%	43.03B
REVOLUTION MEDICINES, INC.	-19.35x	14.12x	-0.58x	285.46x	-17.58x	-17.28x	-.--%	32.71B
IQVIA HOLDINGS INC.	22.08x	4.18x	4.58x	2.54x	10.99x	16.75x	-.--%	30.29B
BEONE MEDICINES AG	39.46x	5.89x	0.24x	3.91x	25.05x	29.65x	-.--%	29.4B
CELLTRION, INC.	29.23x	2.18x	0.88x	7.53x	19.36x	23.11x	0.4%	25.08B
MEDPACE HOLDINGS, INC.	27.43x	13.74x	2.39x	4.4x	20.02x	20.99x	-.--%	13.35B
EUROFINS SCIENTIFIC SE	22.25x	2.33x	0.76x	1.93x	8.48x	13.43x	1.2%	12.97B
IONIS PHARMACEUTICALS, INC.	-20.3x	302.63x	-0.39x	13.35x	-19.88x	-19.33x	-.--%	12.11B
ICON PUBLIC LIMITED COMPANY	23.26x	1.14x	0.2x	1.68x	10.17x	11.65x	-.--%	11.19B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	30.57x	2.74x	-0.1x	2.81x	10.99x	13.33x	-.--%	9.03B
TEMPUS AI, INC.	-23.75x	21.19x	-0.56x	5.79x	142.09x	-447.16x	-.--%	8.59B
BIO-TECHNE CORPORATION	46.31x	3.92x	0.3x	6.94x	19.67x	21.64x	0.59%	8.45B
ABIVAX	-22.11x	38.43x	1.09x	1676.77x	-23.91x	-24.51x	-.--%	7.85B
QIAGEN N.V.	17.68x	2.01x	2.19x	3.8x	10.12x	12.96x	-.--%	7.66B
PRAXIS PRECISION MEDICINES, INC.	-17.51x	6.64x	-1.35x	1535.11x	-14.49x	-13.76x	-.--%	7.43B
ALKERMES PLC	-111.54x	4x	0.87x	4.61x	24.42x	146.52x	-.--%	7.38B
KYMERA THERAPEUTICS, INC.	-24.35x	6.3x	6.01x	69.45x	-15.28x	-14.77x	-.--%	7.09B
Average	2.57x	24.52x	0.98x	205.54x	12.45x	-11.42x	0.19%	15.24B
Weighted average by Cap.	11.55x	20.25x	1.11x	129.46x	11.92x	-0.11x	0.29%